arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

RAPID MICRO BIOSYSTEMS, INC.

RPID

$2.08 ▼ -0.02 (-1.19%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

RAPID MICRO BIOSYSTEMS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $92.9M

Dividend Yield —

Revenue Growth 19.7% ↘

Op. Margin -141.1% ↗

ROIC -91.0% ↘

FCF / Share $-0.71 ↗

Trailing P/E —

Price / Book 2.8x

FCF Yield —

Debt / Equity 0.57

info Valuation on last close. End-of-day price, Aug 6, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$33.59M

↑ +19.7% —

Net Income Profit after all expenses

$-47.12M

— -0.5% —

Operating Margin Operating profit as % of sales

-141.1%

↑ +20.7% 1th

FCF / Share Free cash flow per share

$-0.71

↑ +31.6% —

Long-Term Debt Long-term obligations

$18.90M

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	19.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+295%)	24.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+391%)	31.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+529%)	-26.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-625%)	44.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+790%)	—	—
EPS Growth YoY (%)	2.8% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	11.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	14.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	63.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	96.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-0.5% Weak ↓ Weak Declining Year-over-year change in net income	10.6% Fair ↑ Fair Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	17.3% Good Good Year-over-year change in net income	-98.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	31.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	4.2% Caution ↓ Caution Declining Year-over-year change in free cash flow	29.1% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	47.7% Excellent Excellent Year-over-year change in free cash flow	96.7% Excellent Excellent Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	25.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	6.5% Fair Fair Compound annual revenue growth over 3 years	11.9% Good Good Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	15.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-141.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1276%)	-178.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1583%)	-251.2% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2193%)	-369.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3175%)	-203.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1794%)	-190.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1683%)	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-140.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1854%)	-167.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2189%)	-233.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3012%)	-354.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4536%)	-316.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4056%)	-230.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2983%)	—
FCF Margin (%) (%)	-95.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-162.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-208.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-381.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-250.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-197.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-91.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	30.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-63.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-19.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-43.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-141.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1046%)	-62.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-515%)	-44.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-396%)	-37.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-347%)	-33.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	29.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+95%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.57x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	0.00x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-128%)	—
Interest Coverage (x)	-61.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1247.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1488.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1505.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.82x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-1.13M	$-16.91M	$-24.29M	$-27.06M	$-178.39M	$-5.27M	—
Debt / EBITDA (x)	-0.43x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.85x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.75	$0.64	$0.52	$0.40	$1.17	$44.83	—
Basic EPS, GAAP (USD)	$-1.05	$-1.08	$-1.22	$-1.43	$-3.94	$-126.11	—
Free Cash Flow per Share (USD)	$-0.71	$-1.04	$-1.09	$-1.54	$-2.94	$-88.36	—
Book Value per Share (USD)	$0.74	$1.73	$2.74	$3.87	$11.17	$-354.19	—
Tangible Book Value per Share (USD)	$0.74	$1.73	$2.74	$3.87	$11.17	$-354.19	—
Basic Weighted Avg Shares (shares)	44.68M	43.58M	43.02M	42.45M	19.78M	358,582	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$42.68M	$63.35M	$101.43M	$119.53M	$199.96M	$46.60M	—
LT Debt (USD)	$18.90M	$0.00	—	$0.00	$0.00	$24.81M	—
Total Equity (USD)	$33.21M	$75.35M	$117.99M	$164.17M	$220.98M	$-127.01M	$-82.58M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$33.59M	$28.05M	$22.52M	$17.13M	$23.23M	$16.08M	—
Depreciation Expense (USD)	$3.25M	$3.36M	$3.10M	$2.84M	$1.53M	$1.51M	—
Net Income, GAAP (USD)	$-47.12M	$-46.89M	$-52.47M	$-60.81M	$-73.52M	$-37.08M	—
Operating Cash Flow (USD)	$-31.06M	$-44.15M	$-45.08M	$-58.55M	$-54.96M	$-31.00M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

RAPID MICRO BIOSYSTEMS, INC.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RPID with peers